Sec31 inhibitors constitute a class of small molecules that have garnered significant attention in the field of cell biology and molecular research. These inhibitors are specifically designed to disrupt the function of Sec31, a crucial component of the cellular machinery responsible for intracellular protein trafficking. Sec31 is an integral part of the coat protein complex II (COPII), which plays a central role in the transport of newly synthesized proteins from the endoplasmic reticulum (ER) to the Golgi apparatus. The COPII complex is essential for maintaining the integrity of the secretory pathway within eukaryotic cells, ensuring that proteins are correctly sorted, packaged into vesicles, and delivered to their intended destinations. Sec31 inhibitors, by interfering with the activity of this key player, provide valuable tools for investigating the intricacies of cellular transport processes.
The mechanism of action of Sec31 inhibitors primarily involves disrupting the interactions critical for COPII vesicle formation. Sec31, in collaboration with other COPII components like Sec23, Sec13, and Sar1, plays a pivotal role in assembling the coat that engulfs cargo proteins destined for secretion. These inhibitors may target various aspects of Sec31 function, such as its interaction with other COPII subunits or its phosphorylation status. By inhibiting these interactions or modifications, Sec31 inhibitors impede the formation of COPII vesicles, leading to the accumulation of cargo proteins in the ER. This, in turn, can induce cellular stress responses, including the unfolded protein response (UPR) and ER stress, shedding light on the intricate balance of protein quality control and secretion within cells. As a valuable tool in the research arsenal, Sec31 inhibitors have provided critical insights into the fundamental processes governing intracellular protein trafficking and have contributed significantly to our understanding of cellular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-Methyl Jasmonate | 39924-52-2 | sc-205386 sc-205386A sc-205386B sc-205386C sc-205386D sc-205386E sc-205386F | 1 g 5 g 10 g 50 g 100 g 500 g 1 kg | $35.00 $103.00 $200.00 $873.00 $1638.00 $6942.00 $12246.00 | ||
Induces ER stress and activates the unfolded protein response (UPR), leading to inhibition of SEC31-dependent vesicular trafficking. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $273.00 | 6 | |
Inhibits the GEF activity of SEC7, blocking the activation of ARF GTPases and impairing COPII vesicle formation. | ||||||
4-Phenylbutyric acid | 1821-12-1 | sc-232961 sc-232961A sc-232961B | 25 g 100 g 500 g | $52.00 $133.00 $410.00 | 10 | |
Alleviates ER stress by promoting protein folding, indirectly reducing the demand for SEC31-mediated trafficking. | ||||||
Flavanone | 487-26-3 | sc-205693 sc-205693A | 10 g 25 g | $45.00 $109.00 | ||
Disrupts SEC31 phosphorylation and impairs COPII vesicle budding by interfering with kinase signaling pathways. | ||||||
2-Aminothiazol | 96-50-4 | sc-237914 | 100 g | $21.00 | ||
Inhibits the function of the small GTPase Sar1, disrupting COPII vesicle formation and ER-to-Golgi trafficking. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $270.00 $465.00 $1607.00 $2448.00 $5239.00 | 4 | |
Disrupts SEC31 mRNA translation, reducing the production of SEC31 protein and hindering COPII vesicle formation. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Inhibits N-glycosylation of proteins in the ER, leading to ER stress and indirectly affecting SEC31-dependent vesicular trafficking. | ||||||
β-Pseudouridine | 1445-07-4 | sc-291984 sc-291984A sc-291984B sc-291984C sc-291984D | 10 mg 50 mg 100 mg 250 mg 500 mg | $158.00 $209.00 $362.00 $770.00 $1229.00 | 1 | |
Interferes with RNA processing and causes ER stress, indirectly inhibiting SEC31-mediated vesicular transport. | ||||||